Comment on: Efficacy and safety of enteral recombinant human insulin for reduction of time-to-full enteral feeding in preterm infants: a randomized, double-blind, placebo-controlled trial (IMAJ September 2021)
Isr Med Assoc J
.
2021 Nov;23(11):751.
Author
Robert J Shulman
1
Affiliation
1
Department of Pediatrics, USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
PMID:
34811995
No abstract available
Publication types
Letter
Comment
MeSH terms
Double-Blind Method
Enteral Nutrition*
Humans
Infant
Infant, Newborn
Infant, Premature
Insulins*
Weight Gain
Substances
Insulins